Evidence map›Paper›PMID 37221290›Full record

ArticleBiologia futura2023

Impact analysis of different applications of cyantraniliprole on control of horse chestnut leaf miner (Cameraria ohridella) larvae supported by biophoton emission.

Sándor Keszthelyi, Bálint Gerbovits, Ildikó Jócsák

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Biologia futura, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sándor KeszthelyiInstitute of Agronomy, Hungarian University of Agriculture and Life Sciences, Kaposvár, S. Guba Str. 40, 7400, Gödöllő, Hungary. ostrinia@gmail.com.ORCID http://orcid.org/0000-0001-7966-1001
Bálint GerbovitsInstitute of Agronomy, Hungarian University of Agriculture and Life Sciences, Kaposvár, S. Guba Str. 40, 7400, Gödöllő, Hungary.ORCID http://orcid.org/0000-0002-4814-8210
Ildikó JócsákInstitute of Agronomy, Hungarian University of Agriculture and Life Sciences, Kaposvár, S. Guba Str. 40, 7400, Gödöllő, Hungary.ORCID http://orcid.org/0000-0002-1958-6377
Magyar Agrár- és Élettudományi Egyetem · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cameraria ohridella is one of the most invasive pests of horse chestnut. Cyantraniliprole is one of the most perspectively active insecticides, which can transport within the plant in several ways, and its efficacy against this pest has not yet been tested. All three modes of application were effective against the target pest, but there was a difference in the time of action between them. However, no demonstrable difference in the speed of action was detected between the doses used. A more intense rate of acropetal translocation was confirmed compared to basipetal translocation. A trend-like effect between the applied concentration of cyantraniliprole and the photon emission intensity per unit area of plant tissue was observed in the translaminar and acropetal treatment settings. In both cases, a clear increase in photon emission was observed, indicating metabolic upregulation. Therefore, we can conclude that biophoton emission measurements can be utilized to conduct efficient pesticide translocation investigations.

Indexed as

AesculusMothsAnimalsLarvaortho-AminobenzoatesPyrazolescyantraniliproleortho-AminobenzoatesPyrazolesApplication methodBiophoton emissionChemical controlCyazypyrHorse chestnut leaf miner

Identifiers

PMID37221290
OpenAlexW4377692624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.